Listar por tema "lung embolism"

Ordenar por:Orden:Resultados:

  • Antifibrinolytic therapy to reduce haemoptysis from any cause 
    Prutsky, Gabriela; Pablo Domecq, Juan; Salazar, Carlos A.; Accinelli Tanaka, Roberto Alfonso (Cochrane Collaboration, 2012)
    Background: Haemoptysis is a common pathology around the world, occurring with more frequency in low-income countries. It has different etiologies, many of which have infectious characteristics. Antifibrinolytic agents are ...
  • Cystic echinococcosis: Chronic, complex, and still neglected 
    Brunetti, E.; García Lescano, Héctor Hugo; Junghanss, T. (Public Library of Science, 2011)
    Cystic echinococcosis (CE), an infection with the larval form of the dog tapeworm Echinococcus granulosus, still causes serious lung and liver disease with a worldwide geographical distribution. This parasitic infection ...
  • Tocilizumab in COVID-19: Enthusiasm vs. evidence 
    Zena-Huancas, P.; Leon-Jimenez, F.; Bryce-Alberti, M.; Portmann Baracco, Arianna Sibila (Wolters Kluwer Health, 2021)
    Based on the pathophysiological characterization of COVID-19, initial studies suggested the use of tocilizumab (TCZ), a recombinant humanized monoclonal antibody of the immunoglobulin G1 class, for management of the cytokine ...

Buscar en el Repositorio

Listar

Panel de Control